文献速递银屑病与炎症性皮肤病

英格兰泛发性脓疱型银屑病、掌跖脓疱病与斑块状银屑病的患病率、发病率、死亡率及医疗资源使用:基于人群的队列研究

Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study.
PubMed 文献 · Br J Dermatol · 2024-01-01

该队列研究利用英格兰CPRD Aurum数据库及关联的医院和死亡数据(2008–2019年),比较了泛发性脓疱型银屑病(GPP)、掌跖脓疱病(PPP)与斑块状银屑病的流行病学、共病、死亡率和医疗资源使用。GPP发病率与患病率最低但生存率最差、医疗资源使用最高,提示GPP是与斑块状银屑病不同的独立疾病实体。

要点

  • GPP和PPP的发病率分别为0.25/10万人年和2.01/10万人年,远低于斑块状银屑病的103.2/10万人年。
  • GPP患者生存率低于斑块状银屑病,尤其是55岁以上或合并至少一种共病者。
  • GPP患者医疗资源使用最高,斑块状银屑病最低,多次GPP发作者尤其明显。

核心结论

  • 在英格兰,GPP是具有不同流行病学、更低生存率和更高医疗资源使用的独立疾病,区别于斑块状银屑病。

研究设计与样本

  • 基于英格兰临床实践研究数据链Aurum数据库及关联医院和死亡数据的纵向电子健康记录队列研究,纳入2008–2019年数据。

主要发现

  • GPP、PPP和斑块状银屑病的发病率分别为0.25(95%CI 0.21–0.28)、2.01(95%CI 1.92–2.11)和103.2(95%CI 102.5–103.9)/10万人年。
  • 2008至2019年,GPP每10万人患病率范围为1.61至3.0,PPP为1.1至18.7,斑块状银屑病为1771.0至1903.8。
  • GPP患者平均(SD)年龄55.9(18.6)岁,女性占62.5%;PPP患者51.5(16.4)岁,女性占65.9%;斑块状银屑病患者48.5(19.1)岁,女性占49.4%。
  • 基线超重或肥胖比例:GPP 48.6%、PPP 56.0%、斑块状银屑病45.9%。
  • GPP患者生存率较低,尤其在年龄>55岁及每队列中有一项以上共病者;GPP队列医疗资源使用最高,斑块状银屑病队列最低,多次GPP发作者尤为突出。

临床怎么用

  • 临床应认识GPP与斑块状银屑病为不同疾病实体,对GPP患者需关注共病筛查及生存风险。
  • GPP患者可能需更积极的医疗资源管理与随访,尤其多次发作者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Generalized pustular psoriasis (GPP) and palmoplantar pustulosis (PPP) are chronic inflammatory skin conditions. Accumulating evidence shows that GPP and PPP have different characteristics to plaque psoriasis and are distinct clinical entities. OBJECTIVES: To assess the epidemiology, comorbidities, mortality and healthcare use for patients in England with GPP and PPP versus those with plaque psoriasis. METHODS: We carried out a cohort study involving analyses of longitudinal electronic health record data in the Clinical Practice Research Datalink Aurum database and linked hospital and mortality data between 2008 and 2019. The primary study outcome was the incidence and prevalence rates of GPP, PPP and plaque psoriasis in England. Secondary outcomes included survival rates and healthcare resource use (HCRU) by disease type. RESULTS: We identified 373 patients with GPP, 1828 with PPP and 224 223 with plaque psoriasis. Mean (SD) age was 55.9 (18.6) years for patients with GPP, 51.5 (16.4) years for those with PPP and 48.5 (19.1) years for those with plaque psoriasis; 62.5% and 65.9% of patients with GPP and PPP, respectively, were women, vs. 49.4% of those with plaque psoriasis. About half of patients were overweight or obese at baseline (GPP 48.6%, PPP 56.0%, plaque psoriasis 45.9%). The incidence rates for GPP, PPP and plaque psoriasis were 0.25 [95% confidence interval (CI) 0.21-0.28], 2.01 (95% CI 1.92-2.11) and 103.2 (95% CI 102.5-103.9) per 100 000 person-years, respectively. From 2008 to 2019, the prevalence rates per 100 000 persons ranged from 1.61 to 3.0 for GPP, from 1.1 to 18.7 for PPP and from 1771.0 to 1903.8 for plaque psoriasis. Survival rates were lower for patients with GPP, particularly those who were > 55 years of age and those with a history of one or more comorbidities in each cohort. HCRU was lower in the cohort with plaque psoriasis and highest in the cohort with GPP, particularly among those who had more than one GPP flare. CONCLUSIONS: Our results provide further evidence that, in England, GPP is a distinct disease with different epidemiology, lower survival and higher HCRU than plaque psoriasis. There are several different forms of the inflammatory skin disease called psoriasis. Plaque psoriasis is characterized by flaky or scaly patches of skin. Generalized pustular psoriasis (‘GPP’) causes red skin and painful pustules. Palmoplantar pustulosis (‘PPP’) affects the palms and soles. In this study, we used electronic health record data from general practices that contribute to a database in England called the Clinical Practice Research Datalink (CPRD). We did this to find out how common plaque psoriasis, GPP and PPP are in England and understand how people use healthcare services. The number of patients with these conditions increased between 2008 and 2019. In 2019, the most frequent condition was plaque psoriasis, followed by PPP and GPP. Among people with GPP, 3 out of 5 were women, 7 out of 10 also had a diagnosis of plaque psoriasis and 7 out of 10 had other illnesses. Among people with PPP, about 2 out of 3 were women, 1 out of 3 also had a diagnosis of plaque psoriasis and 2 out of 3 had other illnesses. Overall survival was lowest for people with GPP, particularly those who were older than 55 years of age and those with other illnesses. We found that a higher proportion of patients with GPP were admitted to hospital and visited A&E than those with PPP or plaque psoriasis. These patients also had more outpatient and A&E visits every year. Our results suggest that GPP has a different epidemiology than plaque psoriasis, and patients with GPP use more healthcare services and have a higher mortality rate.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Frysz M, Patel S, Li MOY, et al. Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study. Br J Dermatol. 2024. PMID: 38775029. doi:10.1093/bjd/ljae217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。